Umifenovir addition gives no significant clinical benefit in COVID-19 treatment: Glenmark study EP News Bureau Oct 9, 2020 The FAITH study enrolled a total of 158 hospitalised patients with moderate COVID-19 in India
Glenmark to launch FabiFlu (400 mg) for COVID-19 treatment EP News Bureau Aug 6, 2020 With the new 400 mg version, patients need to consume nine tablets on Day 1, and thereafter two tablets twice a day from Day 2…
